National Vaccine Advisory Committee, 62296-62297 [E8-24893]

Download as PDF 62296 Federal Register / Vol. 73, No. 203 / Monday, October 20, 2008 / Notices Trans No. Acquiring Acquired Entities Transactions Granted Early Termination—06/27/2008 20081257 ........... Comtech Telecommunications Corp. ..... FOR FURTHER INFORMATION CONTACT: Sandra M. Peay, Contact Representative, or Renee Hallman, Contact Representative, Federal Trade Commission, Premerger Notification Office, Bureau of Competition, Room H– 303, Washington, DC 20580, (202) 326– 3100. By Direction of the Commission. Donald S. Clark, Secretary. [FR Doc. E8–24649 Filed 10–17–08; 8:45 am] BILLING CODE 6750–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Vaccine Advisory Committee Department of Health and Human Services, Office of the Secretary, Office of Public Health and Science. ACTION: Notice. AGENCY: mstockstill on PROD1PC66 with NOTICES Authority: 42 U.S.C. 300aa–5, Section 2105 of the Public Health Service (PHS) Act, as amended. The Committee is governed by the provisions of Public Law 92–463, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. SUMMARY: The National Vaccine Program Office (NVPO), a program office within the Office of Public Health and Science, DHHS, is soliciting nominations of qualified candidates to be considered for appointment as members to the National Vaccine Advisory Committee (NVAC). The activities of this Committee are governed by the Federal Advisory Committee Act (FACA). Consistent with the National Vaccine Plan, the Committee advises and makes recommendations to the Assistant Secretary for Health in his capacity as the Director of the National Vaccine Program, on matters related to the Program’s responsibilities. Specifically, the Committee studies and recommends ways to encourage the availability of an adequate supply of safe and effective vaccination products in the United States, and recommends research priorities and other measures to enhance the safety and efficacy of vaccines. The Committee also advises the Assistant Secretary for Health in the implementation of Sections 2102 and 2103 of the PHS Act; and identifies VerDate Aug<31>2005 16:42 Oct 17, 2008 Jkt 217001 Radyne Corporation ............................... annually the most important areas of government and non-government cooperation that should be considered in implementing Sections 2102 and 2103 of the PHS Act. DATES: Nominations for membership on the Committee must be received no later than 5 p.m. EDT on November 21, 2008, at the address below. ADDRESSES: All nominations should be mailed or delivered to: Bruce G. Gellin, MD, MPH, Executive Secretary, NVAC, Office of Public Health and Science, Department of Health and Human Services, 200 Independence Avenue, SW., Room 443–H, Hubert H. Humphrey Building, Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Ms. Andrea Krull, Public Health Advisor, National Vaccine Program Office, Department of Health and Human Services, 200 Independence Avenue, SW., Room 443–H, Hubert H. Humphrey Building, Washington, DC 20201; (202) 690–5566; nvpo@hhs.gov. A copy of the Committee charter which includes the Committee’s structure and functions as well as a list of the current membership can be obtained by contacting Ms. Krull or by accessing the NVAC Web site at: www.hhs.gov/nvpo/nvac. SUPPLEMENTARY INFORMATION: Committee Function, Qualifications, and Information Required: As part of an ongoing effort to enhance deliberations and discussions with the public on vaccine and immunization policy, nominations are being sought for interested individuals to serve on the Committee. Individuals selected for appointment to the Committee will serve as voting members. Public members shall be selected from individuals who are engaged in vaccine research or the manufacture of vaccines, or who are physicians, members of parent organizations concerned with immunizations, representatives of state or local health agencies or public health organizations. Representative members shall be selected from the vaccine manufacturing industry who are engaged in vaccine research or the manufacture of vaccines. Anticipated vacancies include both public and representative member positions. Individuals selected for appointment to the Committee can be invited to serve terms of up to four years. PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 Radyne Corporation. Nominations should be typewritten. The following information should be included in the package of material submitted for each individual being nominated for consideration: (1) A letter of nomination that clearly states the name and affiliation of the nominee, the basis for the nomination (i.e. , specific attributes which qualify the nominee for service in this capacity), and a statement that the nominee is willing to serve as a member of the Committee; (2) the nominator’s name, address and daytime telephone number, and the home and/ or work address, telephone number, and e-mail address of the individual being nominated; and (3) a current copy of the nominee’s curriculum vitae. Applications cannot be submitted by facsimile. The names of Federal employees should not be nominated for consideration of appointment to this Committee. The Department makes every effort to ensure that the membership of HHS Federal advisory committees is fairly balanced in terms of points of view represented and the committee’s function. Every effort is made that a broad representation of geographic areas, gender, ethnic and minority groups, and the disabled are given consideration for membership on HHS Federal advisory committees. Appointment to this committee shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, disability, and cultural, religious, or socioeconomic status. The Standards of Ethical Conduct for Employees of the Executive Branch are applicable to individuals who are appointed as public members of Federal advisory committees. Individuals appointed to serve as public members of Federal advisory committees are classified as special Government employees (SGEs). SGEs are Government employees for purposes of the conflict of interest laws. Therefore, individuals appointed to serve as public members of NVAC are subject to an ethics review. The ethics review is conducted to determine if the individual has any interests and/or activities in the private sector that may conflict with performance of their official duties as a member of the Committee. Individuals appointed to serve as public members of the E:\FR\FM\20OCN1.SGM 20OCN1 Federal Register / Vol. 73, No. 203 / Monday, October 20, 2008 / Notices Committee will be required to disclose information regarding financial holdings, consultancies, and research grants and/or contracts. Dated: October 6, 2008. Bruce Gellin, Director, National Vaccine Program Office, Executive Secretary, National Vaccine Advisory Committee. [FR Doc. E8–24893 Filed 10–17–08; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Biodefense Science Board Department of Health and Human Services, Office of the Secretary. ACTION: Notice. mstockstill on PROD1PC66 with NOTICES AGENCY: SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Services is hereby giving notice that the National Biodefense Science Board (NBSB) will be holding a public meeting. The meeting is open to the public. DATES: The NBSB will hold a public meeting on November 18, 2008 from 8:30 a.m. to 5 p.m. EST and on November 19, 2008 from 8:30 a.m. to 12:30 p.m. ADDRESSES: The Sheraton National Hotel, 900 S. Orme Street, Arlington, VA 22204. Phone: 703–521–1900. FOR FURTHER INFORMATION CONTACT: CAPT Leigh A. Sawyer, D.V.M., M.P.H., Executive Director, National Biodefense Science Board, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, 200 Independence Ave., SW., Room 638G, Washington, DC 20201; 202–205–3815; fax: 202–205– 0613; e-mail address: leigh.sawyer@hhs.gov. SUPPLEMENTARY INFORMATION: Pursuant to section 319M of the Public Health Service Act (42 U.S.C. 247d–7f) and section 222 of the Public Health Service Act (42 U.S.C. 217a), the Department of Health and Human Services established the National Biodefense Science Board. The Board shall provide expert advice and guidance to the Secretary on scientific, technical, and other matters of special interest to the Department of Health and Human Services regarding current and future chemical, biological, nuclear, and radiological agents, whether naturally occurring, accidental, or deliberate. The Board may also provide advice and guidance to the VerDate Aug<31>2005 16:42 Oct 17, 2008 Jkt 217001 62297 Secretary on other matters related to public health emergency preparedness and response. The NBSB will consider recommendations prepared by the Disaster Mental Health Subcommittee. The Subcommittee was established by the NBSB to help fulfill the requirement of HSPD–21, paragraph 31, which directs the Secretary, U.S. Department of Health and Human Services, to convene a committee of subject matter experts and, to submit to the Secretary of Health and Human Services recommendations for protecting, preserving, and restoring individual and community mental health in catastrophic health event settings, including pre-event, intra-event, and post-event education, messaging, and interventions. Additional topics will be considered during the public meeting. A tentative schedule will be made available on November 1, 2008 at the NBSB Web site, https://www.hhs.gov/aspr/omsph/nbsb. This agenda is subject to change as priorities dictate. Any member of the public interested in presenting oral comments at the meeting may notify the Contact person listed on this notice by November 10, 2008. Interested individuals and representatives of an organization may submit a letter of intent and a brief description of the organization represented. In addition, any interested person may file written comments with the committee. All written comments must be received prior to November 10, 2008 and should be sent by e-mail with ‘‘NBSB Public Comment’’ as the subject line or by regular mail to the Contact person listed above. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person. DEPARTMENT OF HEALTH AND HUMAN SERVICES August 8, 2008. William C. Vanderwagen, Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services. [FR Doc. E8–24843 Filed 10–17–08; 8:45 am] SUPPLEMENTARY INFORMATION: BILLING CODE 4150–37–P PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 Administration for Children and Families President’s Committee for People With Intellectual Disabilities; Notice of Meeting President’s Committee for People with Intellectual Disabilities (PCPID). ACTION: Notice of Quarterly Meeting. AGENCY: November 19, 2008, from 8:30 a.m. to 5 p.m. EST; and November 20, 2008, from 8 a.m. to 9.a.m. The meeting will be open to the public. ADDRESSES: The meeting will be held in Room 705A of the Hubert H. Humphrey Building, 200 Independence Ave., SW., Washington, DC 20201. Individuals who would like to participate via conference call may do so by dialing 888–603– 6970, passcode: PCPID. Individuals who will need accommodations for a disability in order to attend the meeting (e.g., sign language interpreting services, assistive listening devices, materials in alternative formats such as large print or Braille) should notify MJ Karimi via email at Madjid.KarimieAsl@ACF.hhs.gov, or via telephone at 202–619–0634, no later than November 12, 2008. PCPID will attempt to meet requests made after that date, but cannot guarantee availability. All meeting sites are barrier free. Agenda: PCPID will meet to continue work on the 2009 Annual Report to the President. Additional Information: For further information, please contact Sally D. Atwater, Executive Director, President’s Committee for People with Intellectual Disabilities, The Aerospace Center, Second Floor West, 370 L’Enfant Promenade, SW., Washington, DC 20447. Telephone: 202–619–0634. Fax: 202–205–9591. E-mail: satwater@acf.hhs.gov. DATES: PCPID acts in an advisory capacity to the President and the Secretary of Health and Human Services on a broad range of topics relating to programs, services and supports for persons with intellectual disabilities. PCPID, by Executive Order, is responsible for evaluating the adequacy of current practices in programs, services and supports for persons with intellectual disabilities, and for reviewing legislative proposals that impact the quality of life experienced by citizens with intellectual disabilities and their families. E:\FR\FM\20OCN1.SGM 20OCN1

Agencies

[Federal Register Volume 73, Number 203 (Monday, October 20, 2008)]
[Notices]
[Pages 62296-62297]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-24893]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Vaccine Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of Public Health and Science.

ACTION: Notice.

-----------------------------------------------------------------------

    Authority: 42 U.S.C. 300aa-5, Section 2105 of the Public Health 
Service (PHS) Act, as amended. The Committee is governed by the 
provisions of Public Law 92-463, as amended (5 U.S.C. Appendix 2), 
which sets forth standards for the formation and use of advisory 
committees.

SUMMARY: The National Vaccine Program Office (NVPO), a program office 
within the Office of Public Health and Science, DHHS, is soliciting 
nominations of qualified candidates to be considered for appointment as 
members to the National Vaccine Advisory Committee (NVAC). The 
activities of this Committee are governed by the Federal Advisory 
Committee Act (FACA).
    Consistent with the National Vaccine Plan, the Committee advises 
and makes recommendations to the Assistant Secretary for Health in his 
capacity as the Director of the National Vaccine Program, on matters 
related to the Program's responsibilities. Specifically, the Committee 
studies and recommends ways to encourage the availability of an 
adequate supply of safe and effective vaccination products in the 
United States, and recommends research priorities and other measures to 
enhance the safety and efficacy of vaccines. The Committee also advises 
the Assistant Secretary for Health in the implementation of Sections 
2102 and 2103 of the PHS Act; and identifies annually the most 
important areas of government and non-government cooperation that 
should be considered in implementing Sections 2102 and 2103 of the PHS 
Act.

DATES: Nominations for membership on the Committee must be received no 
later than 5 p.m. EDT on November 21, 2008, at the address below.

ADDRESSES: All nominations should be mailed or delivered to: Bruce G. 
Gellin, MD, MPH, Executive Secretary, NVAC, Office of Public Health and 
Science, Department of Health and Human Services, 200 Independence 
Avenue, SW., Room 443-H, Hubert H. Humphrey Building, Washington, DC 
20201.

FOR FURTHER INFORMATION CONTACT: Ms. Andrea Krull, Public Health 
Advisor, National Vaccine Program Office, Department of Health and 
Human Services, 200 Independence Avenue, SW., Room 443-H, Hubert H. 
Humphrey Building, Washington, DC 20201; (202) 690-5566; nvpo@hhs.gov.
    A copy of the Committee charter which includes the Committee's 
structure and functions as well as a list of the current membership can 
be obtained by contacting Ms. Krull or by accessing the NVAC Web site 
at: www.hhs.gov/nvpo/nvac.

SUPPLEMENTARY INFORMATION:
    Committee Function, Qualifications, and Information Required: As 
part of an ongoing effort to enhance deliberations and discussions with 
the public on vaccine and immunization policy, nominations are being 
sought for interested individuals to serve on the Committee. 
Individuals selected for appointment to the Committee will serve as 
voting members. Public members shall be selected from individuals who 
are engaged in vaccine research or the manufacture of vaccines, or who 
are physicians, members of parent organizations concerned with 
immunizations, representatives of state or local health agencies or 
public health organizations. Representative members shall be selected 
from the vaccine manufacturing industry who are engaged in vaccine 
research or the manufacture of vaccines. Anticipated vacancies include 
both public and representative member positions. Individuals selected 
for appointment to the Committee can be invited to serve terms of up to 
four years.
    Nominations should be typewritten. The following information should 
be included in the package of material submitted for each individual 
being nominated for consideration: (1) A letter of nomination that 
clearly states the name and affiliation of the nominee, the basis for 
the nomination (i.e. , specific attributes which qualify the nominee 
for service in this capacity), and a statement that the nominee is 
willing to serve as a member of the Committee; (2) the nominator's 
name, address and daytime telephone number, and the home and/or work 
address, telephone number, and e-mail address of the individual being 
nominated; and (3) a current copy of the nominee's curriculum vitae. 
Applications cannot be submitted by facsimile. The names of Federal 
employees should not be nominated for consideration of appointment to 
this Committee.
    The Department makes every effort to ensure that the membership of 
HHS Federal advisory committees is fairly balanced in terms of points 
of view represented and the committee's function. Every effort is made 
that a broad representation of geographic areas, gender, ethnic and 
minority groups, and the disabled are given consideration for 
membership on HHS Federal advisory committees. Appointment to this 
committee shall be made without discrimination on the basis of age, 
race, ethnicity, gender, sexual orientation, disability, and cultural, 
religious, or socioeconomic status.
    The Standards of Ethical Conduct for Employees of the Executive 
Branch are applicable to individuals who are appointed as public 
members of Federal advisory committees. Individuals appointed to serve 
as public members of Federal advisory committees are classified as 
special Government employees (SGEs). SGEs are Government employees for 
purposes of the conflict of interest laws. Therefore, individuals 
appointed to serve as public members of NVAC are subject to an ethics 
review. The ethics review is conducted to determine if the individual 
has any interests and/or activities in the private sector that may 
conflict with performance of their official duties as a member of the 
Committee. Individuals appointed to serve as public members of the

[[Page 62297]]

Committee will be required to disclose information regarding financial 
holdings, consultancies, and research grants and/or contracts.

    Dated: October 6, 2008.
Bruce Gellin,
Director, National Vaccine Program Office, Executive Secretary, 
National Vaccine Advisory Committee.
 [FR Doc. E8-24893 Filed 10-17-08; 8:45 am]
BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.